Evidence map›Paper›PMID 36444621›Full record

ArticleImmunity, inflammation and disease2022

Whey protein hydrolysate mitigates both inflammation and endotoxin tolerance in THP-1 human monocytic leukemia cells.

Fuka Ishikawa, Takeshi Matsubara, Takahiro Koyama, Hiroshi Iwamoto, Kazuhiro Miyaji

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fuka IshikawaHealth Care & Nutrition Science Institute, R&D Division, Morinaga Milk Industry Co. Ltd., Kanagawa, Zama, Japan.
Takeshi MatsubaraHealth Care & Nutrition Science Institute, R&D Division, Morinaga Milk Industry Co. Ltd., Kanagawa, Zama, Japan.ORCID 0000-0001-7407-2451
Takahiro KoyamaHealth Care & Nutrition Science Institute, R&D Division, Morinaga Milk Industry Co. Ltd., Kanagawa, Zama, Japan.
Hiroshi IwamotoHealth Care & Nutrition Science Institute, R&D Division, Morinaga Milk Industry Co. Ltd., Kanagawa, Zama, Japan.
Kazuhiro MiyajiHealth Care & Nutrition Science Institute, R&D Division, Morinaga Milk Industry Co. Ltd., Kanagawa, Zama, Japan.
Megmilk Snow Brand (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt is important to control both inflammation and immunosuppression after severe insults, such as sepsis, trauma, and surgery. Endotoxin tolerance is one of the immunosuppressive conditions and it has been known that endotoxin tolerance relates to poorer clinical outcomes in patients with severe insults. This study investigated whether whey protein hydrolysate (WPH) mitigates inflammation and endotoxin tolerance in THP-1 human monocytic leukemia cells.

methodsEndotoxin tolerance can be experimentally reproduced by two consecutive stimulations with lipopolysaccharide (LPS). THP-1 cells were incubated with LPS and WPH (first stimulation). After collecting the culture supernatant to evaluate the effect on inflammation, the cells were washed and restimulated by 100 ng/ml LPS (second stimulation). The culture supernatant was again collected to evaluate the effect on endotoxin tolerance. Concentrations of LPS and WPH in the first stimulation were adjusted to evaluate their dose dependency. Cytokine levels in the supernatant were determined by enzyme-linked immunosorbent assay. Statistical analysis was performed using the student's t-test or Dunnett's test.

resultsFive mg/ml WPH significantly decreased interleukin (IL)-6 (p = .006) and IL-10 (p < .001) levels after the first LPS stimulation (1000 ng/ml). WPH significantly increased tumor necrosis factor-alpha (p < .001) and IL-10 (p = .014) levels after the second LPS stimulation. The suppressive effect of WPH on inflammation and endotoxin tolerance was dependent on the concentrations of LPS and WPH. The effective dose of WPH for endotoxin tolerance was lower than its effective dose for inflammation.

conclusionWPH mitigated both inflammation and endotoxin tolerance. Therefore, WPH might be a candidate for valuable food ingredients to control both inflammation and immunosuppression after severe insults.

Indexed as

Interleukin-10LeukemiaEndotoxin ToleranceHumansInflammationInterleukin-6LipopolysaccharidesProtein HydrolysatesTHP-1 CellsWheyInterleukin-10Interleukin-6LipopolysaccharidesProtein Hydrolysatesendotoxin toleranceimmunosuppressioninflammationwhey protein hydrolysate

Identifiers

PMID36444621
PMCPMC9639455
OpenAlexW4308471569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.